ZOONO Group: 90 Years of Long-Lasting Antimicrobial Technology Heritage, Safeguarding Global Biosecurity

At a time when global public health security is of paramount concern, ZOONO Group of New Zealand has established itself as a benchmark in the biotechnology sector with its revolutionary 11th-generation molecular physical long- lasting antimicrobial technology. Backed by over 90 years of specialized expertise in sustained antimicrobial solutions, this technology operates through purely physical mechanisms—without reliance on chemical agents—to build a global biosecurity moat spanning healthcare, maternal and child care, animal health, textiles, epidemic prevention, and aviation.

ZOONO Brand Profile: All-Round Protection Powered by Innovative Technology 

ZOONO Group is a New Zealand based bioproducts company listed on the Australian Securities Exchange (ASX: ZNO). Dedicated to the R&D and production of long-lasting sterilization system solutions, ZOONO has established a distinctive presence across multiple sectors, including healthcare, maternal and child care, animal health, textiles, epidemic prevention, and aviation. The company's proprietary molecular physical long-lasting antimicrobial technology employs an entirely novel physical mode of action, forming a durable nanoscale "needle-spike" coating layer on surfaces, skin, and mucous membranes. This layer inactivates microorganisms by physically piercing their cell membranes. This active film adheres to surfaces for up to 30 days and to skin for up to 24 hours (laboratory data), achieving a sterilization rate of 99.9%. As its mechanism is purely physical, it does not induce adaptive changes in microorganisms.

ZOONO Technology: Principles of Action

1. Dense Positively Charged Molecular Needles

ZOONO's technology forms a positively charged "molecular needle" structure on treated surfaces. This dense "needle array" creates a unique "protective shield" across the treated area.

2. Efficient Microbial Disruption

As most pathogen outer membranes carry a negative charge, each positively charged ZOONO "molecular needle" attracts microorganisms like a magnet, effectively disrupting the integrity of their outer membrane structure and causing cellular disintegration and cell death— akin to a pinpoint bursting a balloon upon contact. 

3. Durable Covalent Bonding

Each ZOONO "molecular needle" is anchored to the treated surface via covalent bonds, ensuring stable and lasting attachment whether on inanimate surfaces or on skin.

4. Sustained Microbial Repression

ZOONO provides long- term control and prevents the recolonization of microbial communities on surfaces. Its unique physical mechanism leaves microorganisms with no foothold for colonization or reproduction, delivering protective efficacy lasting up to 30 days on surfaces and 24 hours on skin.

5. Breathable Nanofilm

The nanofilm features high porosity and small pore size, ensuring waterproofing and stain resistance while allowing free air passage. This physical structure effectively prevents the proliferation of anaerobic microorganisms.

Global Pioneer in Epidemic Response: Rigorous Validation from Laboratory to Public Spaces

During the COVID- 19 pandemic in 2020, ZOONO's technology passed relevant testing at the UK's MSL laboratory and received Class I disinfection product registration from China's National Health Commission. The technology was subsequently deployed in the London Underground, Boeing passenger aircraft, and public spaces across more than 60 countries.

Moreover, the technology's safety profile has been endorsed by multiple authoritative bodies, having passed China's food-grade safety testing standards and undergone rigorous evaluation under the EU EN14476 testing framework. Third- party laboratory reports indicate that ZOONO technology achieves an efficacy rate of 99.9% against a broad spectrum of common microorganisms under laboratory conditions. Backed by these data, ZOONO has  become a trusted choice for healthcare systems, maternal and child care, and even veterinary applications.

Cross-Sector Applications: Proven Performance

Healthcare Sector: From surface antimicrobial protection in operating theaters to hand protection for healthcare professionals, ZOONO technology has received multiple international certifications, including from the U.S. EPA, New Zealand GMP, and Australia's TGA, establishing it as an "invisible protective shield" within medical systems across Europe and the Americas.

Animal Health: Addressing the high prevalence of various skin conditions in pets, ZOONO Pet Care Solution leverages its unique "Soft Armor" technology to effectively manage the microbial environment on compromised skin surfaces, supporting adjunctive treatment and symptom relief. It has become a flagship product exclusively distributed by Runhe Pet Supply Chain.

Transportation Hubs: ZOONO Z- 71 coating technology has been applied for disinfection on London Underground carriages, facilities at Los Angeles International Airport, and cabin interiors of United Airlines mainline and United Express aircraft (including Boeing and Airbus series aircraft). Additionally, China Southern Airlines has deployed ZOONO intelligent epidemic-prevention robots in its lounges, establishing a visual epidemic-control system that enhances passenger health protection.

Premium Hospitality: Hilton Hampton Inn Beijing has adopted ZOONO electrostatic spray technology to achieve non-corrosive, 360- degree disinfection across complex scenarios such as carpets and sofas, with ATP testing indicating antimicrobial efficacy lasting over 20 days.

Forward-Looking Vision

Guided by its core philosophy of "long-lasting safety," ZOONO Group has consistently led the development direction of physical surface-protection  technologies—from military submarine antimicrobial applications to civilian product innovations. Looking ahead, its "second-skin" protective network will continue to permeate more facets of daily life, reshaping the health paradigm of human-microbe coexistence.